Radiation therapy Press Release
|06/22/2020 - 10:33||
Orfit Aerial Couch Top for Proton Therapy Validated by Mevion Medical Systems
LITTLETON, MASS, June 22, 2020 – Today, Mevion Medical Systems and Orfit Industries are pleased to announce that the Aerial ® Couch Top is validated for use on the MEVION S250 ® Series Proton Therapy Systems.
|06/17/2020 - 06:58||
Accuray Launches New CyberKnife S7 System
SUNNYVALE, Calif. , June 17, 2020 / / -- Accuray Incorporated (NASDAQ: ARAY) announced today the company has launched the CyberKnife ® S7™ System , an innovative device combining speed, advanced precision, and real-time artificial intelligence (AI)-driven motion tracking and synchronization treatment delivery for all stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments — in as little as 15 minutes.
|06/03/2020 - 04:49||
CAR T Cell Therapy Market Global Forecast by Regions & Targeted Antigens
According to Renub Research analysis CAR-T Cell Therapy Market is expected to be USD 7.4 Billion by 2028. Global Forecast by Regions, Targeted Antigens, Clinical Trials/Study, Companies.
|06/02/2020 - 20:03||
LOCAL WOUND CARE CENTER PARTICIPATES IN SEVENTH ANNUAL HEALOGICS WOUND CARE AWARENESS WEEK
Johnstown, PA 6/3/20 – The Wound Care Center® at Conemaugh Memorial Medical Center, a member of the Healogics network, is helping raise awareness of chronic wounds during the seventh annual Wound Care Awareness Week, being held from June 1 to June 5.
|05/29/2020 - 14:03||
Less Intense Treatment Safe for HPV+ Throat Cancer
PITTSBURGH – A less intense treatment for human papillomavirus positive (HPV+) throat cancer—using robotic surgery followed by low-dose radiation—could provide as much benefit as standard higher-dose radiation and chemotherapy while preserving a patient’s throat function, and with potentially less toxicities, according to researchers at UPMC Hillman Cancer Center and Yale Cancer Center .
|05/19/2020 - 05:55||
Accuray Synchrony Real-time Adaptive Technology for the Radixact System Wins 2020 MedTech Breakthrough Award
SUNNYVALE, Calif. , May 19, 2020 / / -- Accuray Incorporated (NASDAQ: ARAY) today announced that MedTech Breakthrough , an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, has selected the Accuray Synchrony ® Real-time Adaptive Technology for the Radixact ® System as the winner of its "Best Overall Medical Device Solution" award in the fourth annual MedTech Breakthrough Awards program.
|05/11/2020 - 07:59||
Mevion Medical Systems Signs Agreement to Bring Compact Proton Therapy to Texas
LITTLETON, Mass., May 11, 2020 – Mevion Medical Systems announced today that it has signed a letter of intent to provide the MEVION S250i Proton Therapy System® with HYPERSCAN® Pencil Beam Scanning (PBS) to an independent service provider in Texas. The contract is expected to be completed in the second half of 2020. It will be the first compact proton therapy center in Texas.
|05/08/2020 - 15:25||
FDA Approves First Therapy for Patients with Lung and Thyroid Cancers with a Certain Genetic Mutation or Fusion
SILVER SPRING, Md., May 8, 2020 / / -- Today, the U.S. Food and Drug Administration approved Retevmo (selpercatinib) capsules to treat three types of tumors – non-small cell lung cancer, medullary thyroid cancer and other types of thyroid cancers – in patients whose tumors have an alteration (mutation or fusion) in a specific gene (RET or "rearranged during transfection"). Retevmo is the first therapy approved specifically for cancer patients with the RET gene alterations.
|05/08/2020 - 08:18||
New Issue of JAGS Highlights Award-Winning Research at Crossroads of Geriatrics, Urology, Palliative Care, Oncology
New @AmerGeriatrics issue highlighting research originally slated for presentation at @AmerGeriatrics’ #AGS20 includes award-winning research at crossroads of #geriatrics, #urology, #palliative care, #oncology #aging http://ow.ly/NGoE30qE4zC.
|05/07/2020 - 09:55||
Center in Singapore Expanding Access to Radiation Therapy Technology in the Fight Against Cancer
PALO ALTO, Calif., and SINGAPORE, May 7, 2020 / / -- Varian (NYSE: VAR) and the National University Cancer Institute, Singapore (NCIS), are partnering to expand access to cancer solutions in Singapore in the fight against cancer. In 2018, 26,164 cases of cancer were diagnosed in Singapore, and it is expected to more than double to 57,319 cases over the next 20 years.1
|Varian Medical ...|
|05/06/2020 - 10:41||
NANOBIOTIX ANNOUNCES FIRST PHASE I TRIAL WITH NBTXR3 IN PANCREATIC CANCER
We are pleased that the FDA has been able to advance the regulatory process in this complex environment. We look forward to the opportunity to begin treating pancreatic cancer patients and finding ways to make a difference in their lives.” – Laurent Levy, CEO of Nanobiotix.
|05/06/2020 - 09:36||
Fox Chase Researchers Study Risks of Recurrence in Lung Cancer Patients Receiving Stereotactic Body Radiation
That’s why we wanted to pick those people who would benefit the most,” said Kumar. PHILADELPHIA (May 6, 2020)—A study by researchers at Fox Chase Cancer Center has investigated which tumor factors increase the risk of a patient’s cancer spreading to other areas of the body following treatment with stereotactic body radiation therapy (SBRT) alone in patients with lung cancer.
|Fox Chase Cance...|
|05/05/2020 - 10:54||
MRI technique could reduce need for radiation in measuring tumor response to chemotherapy
Whole body diffusion-weighted magnetic resonance imaging (DW MRI) may aid in the assessment of cancer treatment response in children and youth at much lower levels of radiation than current approaches, suggests a small study funded by the National Institutes of Health. The results appear in Radiology.
|05/04/2020 - 20:51||
Despite COVID-19, PetCure Oncology Network Expands into Houston
Sugar Land, TX – May 5, 2020 – COVID-19 has presented countless barriers to people and businesses around the world over the past few months, but it will not stop pets in the Houston area from gaining access to life-changing cancer care.
|05/04/2020 - 18:21||
Gene research could lead to cancer breakthrough
New research by scientists at The Australian National University (ANU) will help us better understand rare forms of cancer.
|05/01/2020 - 14:12||
Brain tumors respond well to combo of radiation, schizophrenia drug
Researchers at the UCLA Jonsson Comprehensive Cancer Center and colleagues have found that adding a drug once commonly used to treat schizophrenia to traditional radiation therapy helped improve overall survival in mice with glioblastoma, one of the deadliest and most difficult-to-treat brain tumors.
|04/30/2020 - 15:08||
Leading Cancer Treatment Center Admits to Antitrust Crime and Agrees to Pay $100 Million Criminal Penalty
Florida Cancer Specialists & Research Institute LLC (FCS), an oncology group headquartered in Fort Myers, Florida, was charged with conspiring to allocate medical and radiation oncology treatments for cancer patients in Southwest Florida, the Department of Justice announced. This charge is the first in the department’s ongoing investigation into market allocation in the oncology industry.
|04/27/2020 - 12:14||
AdvaMed Joins Global Coalition to Promote Patient Access to Radiotherapy
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) has joined with several groups representing medical professionals, advocacy groups, international societies and the health care industry to form The Global Coalition for Radiotherapy (TGCR) to ensure cancer patients have access to this vital therapy during the COVID-19 pandemic and beyond.
|04/27/2020 - 11:01||
Immunotherapy Before Surgery Could Advance Care of an Aggressive Form of Skin Cancer
Immune “checkpoint” inhibitor treatment found useful against Merkel cell carcinoma in multicenter clinical trial.
|Johns Hopkins H...|
|04/27/2020 - 06:22||
How Immunotherapy for Esophageal Cancer is Making an Impact
Each year, esophageal cancer affects an estimated 500,000 people worldwide, including 17,000 in the U.S. When caught early, esophageal cancer can often be treated successfully, but the more it progresses, the worse a patient’s prognosis becomes. Once the disease has metastasized, or spread to other organs, only five percent of these patients live beyond five years.
|04/24/2020 - 13:39||
SegAna Approved for COVID-19 Fastlane Project Pitch by National Science Foundation
Friday, April 24, 2020 () SegAna Approved for COVID-19 Fastlane Project Pitch by National Science Foundation.
|04/24/2020 - 07:55||
FUJIFILM Toyama Chemical starts a Phase I Clinical Trial of FF-21101 for the Treatment of Advanced Solid Tumors in Japan
FF-21101 specifically delivers radiation to the cancer tissues and is expected to demonstrate efficacy in shrinking solid tumors.
|04/23/2020 - 08:24||
MEVION S250i Proton Therapy System Receives Approval from Health Canada
LITTLETON, Mass., April 23, 2020 – Mevion Medical Systems announced today that the MEVION S250i Proton Therapy System® with HYPERSCAN® Pencil Beam Scanning (PBS) has received a Medical Device License from Health Canada, opening the door for commercial sales in Canada. The MEVION S250i is the only proton therapy system approved for use in Canada.
|04/22/2020 - 17:46||
FDA Approves New Therapy for Triple Negative Breast Cancer That Has Spread, Not Responded to Other Treatments
Today, the U.S. Food and Drug Administration granted accelerated approval to Trodelvy (sacituzumab govitecan-hziy) for the treatment of adult patients with triple-negative breast cancer that has spread to other parts of the body. Patients must have received at least two prior therapies before taking Trodelvy.
|04/22/2020 - 00:07||
IntraOp Announces First Patient Enrolled in Cosmopolitan Trial for Breast Cancer
Study to demonstrate the superiority of a single treatment of electron-beam IORT compared with weeks of standard radiation therapy.